. Author manuscript; available in PMC: 2018 Aug 1.

Published in final edited form as: Transplantation. 2017 Aug;101(8):1859–1866. doi: 10.1097/TP.0000000000001725

Table 3.

Types of consecutive malignancies in 9 patients who developed multiple de novo malignancies after LT

N	1^st Cancer	Time to cancer(yrs)	2^nd Cancer	Time to cancer(yrs)
1	Breast	2.1	Hodgkin’s disease	10.1
2	Colon	6.2	RCC	15.5
3	RCC	6.0	Prostate	19.0
4	Prostate	4.0	RCC	17.3
5	Prostate	1.9	AML	9.8
6	RCC	3.5	Prostate	6.2
7	RCC	5.2	CCA	9.4
8	PTLD	4.6	AML	16.7
9	PTLD	6.9	CCA	20.5

RCC, renal cell cancer; AML, acute myeloid leukemia; CCA, cholangiocarcinoma; PTLD, posttransplant proliferative disorder.